Drug Shortage Report for TEVA-TEMOZOLOMIDE
Report ID | 123093 |
Drug Identification Number | 02395282 |
Brand name | ACT TEMOZOLOMIDE |
Common or Proper name | TEMOZOLOMIDE 100MG CAP |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | TEMOZOLOMIDE |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 5 |
ATC code | L01AX |
ATC description | ALKYLATINGAGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-08-26 |
Estimated end date | 2020-09-30 |
Actual end date | 2020-09-09 |
Shortage status | Resolved |
Updated date | 2020-09-10 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-08-27 | English | Compare |
v2 | 2020-08-27 | French | Compare |
v3 | 2020-09-10 | English | Compare |
Showing 1 to 3 of 3